Cost of illness in subarachnoid hemorrhage: A German Longitudinal Study

Stroke

Volumn 41, Issue 12, 2010, Pages 2918-2923

  Dodel, Richard ^a   Winter, Yaroslav ^a   Ringel, Florian ^b   Spottke, Annika ^c   Gharevi, Nadir ^c   Müller, Ines ^a   Klockgether, Thomas ^b   Schramm, Johannes ^c   Urbach, Horst ^c   Meyer, Bernhard ^b  

^a PHILIPPS UNIVERSITY MARBURG   (Germany)

^b TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^c UNIVERSITY OF BONN   (Germany)

Author keywords

costs; outcome; subarachnoid hemorrhage

Indexed keywords

ADULT; AGED; ARTICLE; BARTHEL INDEX; BRAIN ARTERY ANEURYSM; CLINICAL ASSESSMENT; COST OF ILLNESS; FEMALE; FOLLOW UP; GERMANY; HEALTH CARE PRACTICE; HEALTH INSURANCE; HUMAN; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MULTIPLE REGRESSION; PRIORITY JOURNAL; QUESTIONNAIRE; RANKIN SCALE; SUBARACHNOID HEMORRHAGE; TREATMENT OUTCOME;

ADULT; AGED; COST OF ILLNESS; FEMALE; GERMANY; HUMANS; INSURANCE, HEALTH; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; SOCIOECONOMIC FACTORS; SUBARACHNOID HEMORRHAGE;

EID: 78650420397     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/STROKEAHA.110.586826     Document Type: Article

References (30)

1. Rivero-Arias O, Wolstenholme J, Gray A, Molyneux AJ, Kerr RS, Yarnold JA, Sneade M. The costs and prognostic characteristics of ischaemic neurological deficit due to subarachnoid haemorrhage in the United Kingdom. Evidence from the MRC International Subarachnoid Aneurysm trial. J Neurol. 2009;256:364-373.
2. Winter Y, Wolfram C, Schoffski O, Dodel RC, Back T. Long-term disease-related costs 4 years after stroke or TIA in Germany. Nervenarzt. 2008;79:918-926.
3. Winter Y, Wolfram C, Schaeg M, Reese JP, Oertel WH, Dodel R, Back T. Evaluation of costs and outcome in cardioembolic stroke or TIA. J Neurol. 2009;256:954-963.
4. De Rooij NK, Linn FH, Van Der Plas JA, Algra A, Rinkel GJ. Incidence of subarachnoid haemorrhage: A systematic review with emphasis on region, age, gender and time trends. J Neurol Neurosurg Psychiatry. 2007;78:1365-1372.
5. The Federal Statistical Office Germany. Epidemiology of cerebrovascular diseases in Germany. Available at: www.gbe-und.de/gbe10/trecherche. prc-them-rech2?tk = 8500& tk2 = 8700&ut
6. Kolominsky-Rabas PL, Heuschmann PU, Marschall D, Emmert M, Bnurs NB, Neundoerfer B, Schoeffski O, Krobot KJ. Lifetime cost of ischemic stroke in Germany: results and national projections from a population-based stroke registry: the Erlangen Stroke Project. Stroke. 2006;37:1179-1183.
7. Venketasubramanian N, Yin A. Hospital costs for stroke care in Singapore. Cerebrovasc Dis. 2000;10:320-326.
8. Epifanov Y, Dodel R, Haacke C, Schaeg M, Schoeffski O, Hennerici M, Back T. Costs of acute stroke care on regular neurological wards: a comparison with stroke unit setting. Health Policy. 2007;81:339-349.
9. Back T, Schaeg M, Back C, Epifanov Y, Hemmen T, Dodel RC, Schoffski O. Costs of stroke unit care in Germany. Resource use and reimbursements by German diagnosis related groups [in German]. Nervenarzt. 2004;75: 991-999.
10. Yundt KD, Dacey RGJ, Diringer MN. Hospital resource utilization in the treatment of cerebral aneurysms. J Neurosurg. 1996;85:403-409.
11. Bairstow P, Dodgson A, Linto J, Khangure M. Comparison of cost and outcome of endovascular and neurosurgical procedures in the treatment of ruptured intracranial aneurysms. Australas Radiol. 2002;46:249-251.
12. Roos YB, Dijkgraaf MG, Albrecht KW, Beenen LF, Groen RJ, de Haan RJ, Vermeulen M. Direct costs of modern treatment of aneurysmal subarachnoid hemorrhage in the first year after diagnosis. Stroke. 2002; 33:1595-1599.
13. Teasdale GM, Drake CG, Hunt W, Kassell N, Sano K, Pertuiset B, De Villiers JC. A universal subarachnoid hemorrhage scale: report of a committee of the World Federation of Neurosurgical Societies. J Neurol Neurosurg Psychiatry. 1988;51:1457.
14. Hunt WE, Hess RM. Surgical risk as related to time of intervention in the repair of intracranial aneurysms. J Neurosurg. 1968;28:14-20.
15. Mahoney FI, Barthel DW. Functional evaluation: the Barthel Index. Md State Med J. 1965;14:61-65.
16. Rankin J. Cerebral vascular accidents in patients over the age of 60. Scott Med J. 1957;2:200-215.
17. Beck A, Ward CH, Mendelson M, Mock J, Erbaugh J. An inventory for measuring depression. Arch Geriatr Psychiatry. 1961;4:561-567.
18. Folstein MF, Folstein SE, McHugh PR. 'Mini-mental state': a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975;12:189-198.
19. The EuroQol Group. EuroQol- a new facility for the measurement of health-related quality of life. Health Policy. 1990;16:199-208.
20. Schepelmann K, Winter Y, Spottke AE, Claus D, Grothe C, Schroder R, Heuss D, Vielhaber S, Mylius V, Kiefer R, Schrank B, Oertel WH, Dodel R. Socioeconomic burden of amyotrophic lateral sclerosis, myasthenia gravis and facioscapulohumeral muscular dystrophy. J Neurol. 2010;257: 15-23.
21. Von Campenhausen S, Winter Y, Gasser J, Seppi K, Reese JP, Pfeiffer KP, Geiger-Gritsch S, Botzel K, Siebert U, Oertel WH, Dodel R, Poewe W. Cost of illness and health services patterns in Morbus Parkinson in Austria. Wien Klin Wochenschr. 2009;121:574-582.
22. Winter Y, von Campenhausen S, Popov G, Reese JP, Klotsche J, Botzel K, Gusev E, Oertel WH, Dodel R, Guekht A. Costs of illness in a Russian cohort of patients with Parkinson's disease. Pharmacoeconomics. 2009; 27:571-584.
23. The German Diagnosis Related Groups (G-DRG). The official reimbursement catalogue of the German Diagnosis-Related Groups in 2005. Available at: www.g-drg.de/cms/index.php/inek-site-de/layout/set/standard/ Archiv/Systemjahr-2005-bzw.-Datenjahr-2003#sm2. Accessed December, 15, 2009.
24. Deutscher Arzteverlag. Einheitlicher Bewertungsmasstab. Koln: Deutscher Arzteverlag; 2006.
25. The Federation of German Pharmaceutical Industry. Rote liste. Weinheim: Rote Liste Verlag, 2006.
26. The Federal Ministry for Health and Social Secure. Available at: www. bmg.bund.de. Accessed January 5, 2010.
27. Barber JA, Thompson SG. Analysis of cost data in randomized trials: an application of the non-parametric bootstrap. Stat Med. 2000;19: 3219-3236.
28. Efron B, Tibshirani RJ. An Introduction to the Bootstrap. London: Chapman and Hall; 1993.
29. Bardach NS, Olson SJ, Elkins JS, Smith WS, Lawton MT, Johnston SC. Regionalization of treatment for subarachnoid hemorrhage: a cost-utility analysis. Circulation. 2004;109:2207-2212.
30. Harrell FE. Regression Modeling Strategies. New York: Springer; 2001.